ARLINGTON, Va. — The U.S. National Nuclear Security Administration (NNSA) could soon award a new tranche of funding to support U.S. commercial manufacturing of the medical isotope molybdenum-99, a senior official said this week.
“We’re working through…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.







